![]() |
|
Clinical Trials Because clinical trials are so important to the process of developing new drugs and treatments for Alzheimers disease Mild Cognitive Impairment and age-associated memory impairment, and because they provide hope for patients beyond the benefits of existing treatments, the ADRC actively supports this type of research by conducting clinical trials of the latest experimental treatments.
Who can participate? Clinical trials are open to all patients who have completed an evaluation at the NYU Silberstein Aging and Dementia Research Center and who meet the specific requirements of a particular trial. What are the benefits of participating? Clinical trials at the ADRC:
*The benefits and risks associated with any particular trial will be discussed individually with each eligible participant at the time of enrollment in the trial. What is the enrollment procedure for clinical trials? In order to enroll in a clinical trial and take full advantage of its benefits, a patient must complete the following steps:
Who is involved in a patients care during the clinical trial? The ADRC Clinical Trials Coordinator schedules all clinical visits and organizes all aspects of a patients participation in the clinical trial. All medical staff and counselors working on a particular clinical trial provide healthcare services and monitoring as outlined in the clinical trial care plan. Also, the patients primary care physician is consulted throughout the clinical trial. To inquire about clinical trials at the ADRC, call Maria Vlassopoulos, Clinical Trials Coordinator, at (212) 263-5708
|
|
About
the ADRC | For Patients & Families
| For Professionals | Programs
& Services
|
|
Silberstein Aging & Dementia Research Center New York University School of Medicine © 2002 New York University Ethics and Disclaimer |
|
![]() |
![]() |